Pampee Young
Associate Professor of Pathology
Last active: 10/24/2017


Dr. Pampee Paul Young is Professor of Pathology and Medicine at Vanderbilt University. She is also the Director of Transfusion Medicine and Stem Cell Laboratory at Vanderbilt Medical Center and the Department of Veterans Affairs.

Dr. Young graduated from Rice University with a B.A. in 1990 and received a Ph.D and M.D. from the University of Texas Southwestern 1998. At Washington University Dr. Young completed fellowships in Clinical Pathology, serving as Chief Resident for one year and subsequently a fellowship in Blood Banking and Transfusion Medicine.


The following timeline graph is generated from all co-authored publications.

  1. Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species. Ardestani S, Deskins DL, Young PP (2013) J Mol Signal 8(1): 12
    › Primary publication · 24180579 (PubMed) · PMC3895838 (PubMed Central)
  2. Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure. Gehrie EA, Nian H, Young PP (2013) PLoS One 8(9): e76558
    › Primary publication · 24086749 (PubMed) · PMC3785411 (PubMed Central)
  3. Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsis. Janz DR, Zhao Z, Koyama T, May AK, Bernard GR, Bastarache JA, Young PP, Ware LB (2013) Ann Intensive Care 3(1): 33
    › Primary publication · 24059842 (PubMed) · PMC3848804 (PubMed Central)
  4. Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells. Ardestani S, Li B, Deskins DL, Wu H, Massion PP, Young PP (2013) Cancer Res 73(13): 3938-50
    › Primary publication · 23704210 (PubMed) · PMC3702680 (PubMed Central)
  5. Human mesenchymal stromal cells: identifying assays to predict potency for therapeutic selection. Deskins DL, Bastakoty D, Saraswati S, Shinar A, Holt GE, Young PP (2013) Stem Cells Transl Med 2(2): 151-8
    › Primary publication · 23362238 (PubMed) · PMC3659751 (PubMed Central)
  6. Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation. Gehrie EA, Cates JM, Nian H, Olson SJ, Young PP (2013) Cardiovasc Pathol 22(4): 251-6
    › Primary publication · 23290353 (PubMed) · PMC4795169 (PubMed Central)
  7. A physiological role for connective tissue growth factor in early wound healing. Alfaro MP, Deskins DL, Wallus M, DasGupta J, Davidson JM, Nanney LB, A Guney M, Gannon M, Young PP (2013) Lab Invest 93(1): 81-95
    › Primary publication · 23212098 (PubMed) · PMC3720136 (PubMed Central)
  8. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. Alfaro MP, Vincent A, Saraswati S, Thorne CA, Hong CC, Lee E, Young PP (2010) J Biol Chem 285(46): 35645-53
    › Primary publication · 20826809 (PubMed) · PMC2975189 (PubMed Central)
  9. Atheromas feel the pressure: biomechanical stress and atherosclerosis. Pyle AL, Young PP (2010) Am J Pathol 177(1): 4-9
    › Primary publication · 20558573 (PubMed) · PMC2893643 (PubMed Central)
  10. Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis. Cates JM, Friedman DB, Seeley EH, Dupont WD, Schwartz HS, Holt GE, Caprioli RM, Young PP (2010) Int J Exp Pathol 91(4): 335-49
    › Primary publication · 20353421 (PubMed) · PMC2962892 (PubMed Central)